Stay updated on HMPL-523 in Lymphoma Patients Clinical Trial
Sign up to get notified when there's something new on the HMPL-523 in Lymphoma Patients Clinical Trial page.

Latest updates to the HMPL-523 in Lymphoma Patients Clinical Trial page
- Check5 days agoChange DetectedResults status updated to 'Results Submitted' and new site locations added (California, New Jersey, New York, North Carolina, Texas, Milano), with the page revision noted as v3.3.3.SummaryDifference0.7%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedThe page shows an updated site revision label from v3.2.0 to v3.3.2, with no changes to study content or user-facing details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedThe funding-status notice on the page was removed; all trial details, including eligibility criteria, outcomes, and locations, remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check55 days agoChange DetectedThe two screenshots show the same study details with only minor non-substantive differences, such as a later last update date and light formatting tweaks; core content (design, eligibility, and outcomes) remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check84 days agoChange DetectedUpdate adds a government-operations notice and a new version tag (v3.2.0); removes a specific disease mention (B-cell chronic lymphocytic leukemia). The biggest impact is the new operating-status notice affecting page reliability guidance.SummaryDifference3%

- Check91 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes are described.SummaryDifference0.1%

Stay in the know with updates to HMPL-523 in Lymphoma Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HMPL-523 in Lymphoma Patients Clinical Trial page.